1. Home
  2. COGT vs HOMB Comparison

COGT vs HOMB Comparison

Compare COGT & HOMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

N/A

Current Price

$39.53

Market Cap

6.5B

Sector

Health Care

ML Signal

N/A

Logo Home BancShares Inc.

HOMB

Home BancShares Inc.

N/A

Current Price

$28.82

Market Cap

5.6B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
COGT
HOMB
Founded
2014
1998
Country
United States
United States
Employees
N/A
2552
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
5.6B
IPO Year
2018
2006

Fundamental Metrics

Financial Performance
Metric
COGT
HOMB
Price
$39.53
$28.82
Analyst Decision
Buy
Hold
Analyst Count
13
5
Target Price
$28.08
$32.40
AVG Volume (30 Days)
2.9M
1.2M
Earning Date
11-03-2025
01-14-2026
Dividend Yield
N/A
2.93%
EPS Growth
N/A
18.95
EPS
N/A
2.30
Revenue
N/A
$1,042,417,000.00
Revenue This Year
N/A
$13.21
Revenue Next Year
N/A
$3.01
P/E Ratio
N/A
$12.48
Revenue Growth
N/A
7.75
52 Week Low
$3.72
$24.22
52 Week High
$43.73
$31.27

Technical Indicators

Market Signals
Indicator
COGT
HOMB
Relative Strength Index (RSI) 64.24 60.37
Support Level $37.86 $28.53
Resistance Level $42.25 $29.05
Average True Range (ATR) 2.10 0.51
MACD -0.73 0.05
Stochastic Oscillator 29.68 81.13

Price Performance

Historical Comparison
COGT
HOMB

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About HOMB Home BancShares Inc.

Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The bank also emphasizes attracting experienced bankers, credit quality and a solid balance sheet. The bank's main source of net revenue is net interest income.

Share on Social Networks: